Patent · US Active

CA2 compositions and methods for tunable regulation

US11058725B2 · kind B2 · utility

1Cited by

44References

21Claims

0Family size

Assignee

OBSIDIAN THERAPEUTICS, INC. · US

Inventors

Kutlu Goksu Elpek · Arlington, US
Dhruv Kam Sethi · Westwood, US
Meghan C. Langley · Stoughton, US
Tucker Read EZELL · Acton, US
Dexue Sun · Cambridge, US
Jennifer Leah GORI · Brookline, US
Geetha MYLVAGANAM · Boston, US
Michelle Lynn Ols · Northborough, US
Michelle FLEURY · Cambridge, US
Celeste Richardson · Cambridge, US
James Storer · Medford, US
Vipin Suri · Belmont, US
Shyamsundar Subramanian · Lansdale, US
Colleen Foley · Cambridge, US
Molly R. Perkins · Milton, US
Jeremy Hatem Tchaicha · Belmont, US
Scott Francis Heller · Stoughton, US

Key dates

Filing date	Sep 10, 2020
Grant date	Jul 13, 2021
Priority date	—
Expiry date	Sep 10, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides drug responsive domains derived from human carbonic anhydrase 2 that can modulate protein stability for human interleukin 15 (IL15) payloads, as well as compositions and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.